Outlook Wealth Advisors LLC Acquires New Shares in Invesco Pharmaceuticals ETF $PJP

Outlook Wealth Advisors LLC bought a new stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 11,290 shares of the company’s stock, valued at approximately $1,392,000. Outlook Wealth Advisors LLC owned about 0.25% of Invesco Pharmaceuticals ETF at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Bank of America Corp DE raised its stake in shares of Invesco Pharmaceuticals ETF by 234.0% in the first quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock worth $7,726,000 after purchasing an additional 52,165 shares during the last quarter. Royal Bank of Canada boosted its position in shares of Invesco Pharmaceuticals ETF by 479.8% during the first quarter. Royal Bank of Canada now owns 62,377 shares of the company’s stock valued at $6,472,000 after buying an additional 51,619 shares during the last quarter. Cetera Investment Advisers increased its holdings in Invesco Pharmaceuticals ETF by 250.7% in the 1st quarter. Cetera Investment Advisers now owns 20,462 shares of the company’s stock worth $2,123,000 after buying an additional 14,628 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in Invesco Pharmaceuticals ETF by 35.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 36,897 shares of the company’s stock worth $4,370,000 after buying an additional 9,741 shares in the last quarter. Finally, Private Advisor Group LLC bought a new stake in Invesco Pharmaceuticals ETF in the 1st quarter worth about $610,000.

Invesco Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:PJP opened at $130.54 on Friday. Invesco Pharmaceuticals ETF has a fifty-two week low of $95.43 and a fifty-two week high of $131.88. The business has a 50-day simple moving average of $125.80 and a two-hundred day simple moving average of $114.46. The firm has a market cap of $579.60 million, a price-to-earnings ratio of 15.59 and a beta of 0.44.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.